PharmaTelevision - BioAngels: Dr John Ballard

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BioAngels: Dr John Ballard

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this episode of PharmaTelevision News Review, Fintan Walton talks to Dr John Ballard, Chair of BioAngels Inc.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

John Ballard 's role and involvement in GroPep and growth factor

Fintan Walton:

Hello and welcome to PharmaTelevision News Review here at AusBiotech in Melbourne in October 2010. On this show I have John Ballard , who is Chairman of BioAngels based in Adelaide, in Australia. Welcome to the show.

John Ballard :

Thank you.

Fintan Walton:

John, you are a I could describe you as a veteran of the biotechnology industry here in Australia. You have lot of experience in biotech particularly, because you founded one of the first biotech companies here in Australia, and I'd like you to tell me the story about how you set that company up, and also to find out more about your experience has been now an Angel investor, so lets go back to those early days and how it came about that you set up this company called GroPep?

John Ballard :

Yes thank you, what happened was that myself and a colleague in the university at 00:01:12 had developed, discovered an entirely new growth factor, we licensed it or trying to license it to a major pharmaceutical company or may be major biotechnology company and what we found was that the company wasn't particularly interested in talking to a lot of different people they wanted one entity and that's where the university and CSIRO who I worked for decided to set up GroPep, and I joined it initially part time as CEO and the licensing deal went through.

Fintan Walton:

Now tell us a little bit about the growth factor, because you had ambitions for it, but it went in a particular direction, so the growth factor was?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Fintan Walton

Dr Fintan Walton is the Founder and CEO of PharmaVentures . After completing his doctoral research on the genetics of cell proliferation at the University of Michigan(US)and Trinity College (Dublin, Ireland), Dr Walton gained broad commercial experience in biotechnology in management positions at Bass and Celltech plc (1982-1992).

John Ballard

Chairman

John Ballard was Managing Director and previously CEO of the GroPep Ltd until 2002, positions he held since the inception of the company in 1988 and through its listing on the ASX in 2000. He was one of the founders of BioAngels , of which he is currently Chairman. He is also a Director of BR-Angels Pty Ltd, Applimex Pty Ltd, AdAlta Pty Ltd and Neubody Pty Ltd as well as the not-for-profit companies, Australian Proteome Analysis Facility Ltd, The Australian Association of Angel Investors Ltd and the Australian Institute for Commercialization Ltd. He is a biochemist by training (PhD, BSc), has authored more than 300 research publications and is an inventor of 10 patents. He was elected to the Australian Academy of Technological Sciences and Engineering in 1997.

PharmaVentures

PharmaVentures is a corporate finance and transactions advisory firm that has served hundreds of clients worldwide in relation to their strategic deal making in the pharmaceutical, life science and healthcare sectors. Our key offerings include: Transactions / deal negotiations; Product / technology valuations; Deal term advice; Due diligence & expert reports; Strategy formulation; Alliance management; and Expert opinion for litigation/arbitration cases. PharmaVentures provides the global expertise to ensure our clients generate the highest possible return on investment from all their deal making activities. We have experience of all therapeutic areas and can offer advice on both product and technology commercialisation.

BioAngels Inc

BioAngels Inc. is a not-for-profit association of business executives and entrepreneurs from a wide range of backgrounds. Established in 2002 by a group of founding members including, Dr John Ballard, Mr Paul Flavel, Mr Ron Langman and Dr Oliver Mayo. In 2010, the group has 20 active members and is looking to expand its membership.